Skip to main content
Caplight Logo









BioSerenity

BioSerenity

Private
ParisHealthcare & Life Scienceshttps://bioserenity.ai/

Last Round

Recap

Nov 13, 2023

Total Funding Raised

$94.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

BioSerenity is a medical technology company that develops connected medical devices and AI-powered digital health solutions for remote patient monitoring in neurology, cardiology, and sleep disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Telemedicine, Health IoT, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting, Hardware Sales

AI Layer

Foundation

Keywords

neurodiagnosticremote patient monitoringEEG monitoringmedical AIhardware-as-a-serviceHaaStelemedicinecardiac monitoringfoundation modelfrontier AI labwearable medical devicehealth IoTcompanion diagnosticselectrophysiological signalsclinical trial software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioSerenity Comparables

Compare BioSerenity with similar companies based on industry and business-model similarity.

BioSerenity comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stratus
84%
Zeto, Inc.
81%
Seer Medical
78%

BioSerenity Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
RecapNov 13, 2023
Series BJun 18, 2019
Series ASep 20, 2017
SeedJun 8, 2015

Key People

Founding team and executive leadership

Jean-Yves Lagarde

US CEO

Executive Team

Pierre Emerich

Chief Technology Officer

Executive Team

Olivier Auton

Group CFO

Executive Team

Damien MICHON

COO Directeur Des Operations

Executive Team

BioSerenity Investors

Notable investors and investment history

BioSerenity investors
InvestorRounds
Idinvest PartnersSeries A, Series B, Seed
Dassault SystèmesSeries B
Jolt CapitalRecap
LBO FranceSeries B, Series A
BpifranceSeries A, Series B
Kurma PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    New sleep center planned for Auxerre, France in September 2026.

  • Jun 24, 2026

    Monthly visitors grew 35% MoM, reaching 8.4K.

BioSerenity Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioSerenity Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioSerenity's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range273
Year Founded2014
Last FundingNov 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?